Literature DB >> 20814314

Triage and management of pericardial effusion.

Massimo Imazio1, Bongani M Mayosi, Antonio Brucato, Gal Markel, Rita Trinchero, David H Spodick, Yehuda Adler.   

Abstract

Pericardial effusion may be detected as an incidental finding during echocardiography or following a diagnostic imaging study for a symptomatic patient. When a pericardial effusion is detected the first step is to assess its size, hemodynamic importance, and possible associated diseases. The more common causes of pericardial effusions include infections (viral, bacterial, especially tuberculosis), cancer, connective tissue diseases, pericardial injury syndromes, metabolic causes (i.e. hypothyroidism), myopericardial and aortic diseases. The relative frequency of different causes depends on the local epidemiology, the hospital setting and the diagnostic protocol that has been adopted. Many cases still remain idiopathic in developed countries, whereas tuberculosis is the dominant cause in developing countries. Specific testing should be performed according to clinical suspicion. The presence of elevated inflammatory markers and other criteria (chest pain, pericardial rubs, ECG changes) suggest pericarditis and management should be directed accordingly. Treatment should be targeted at the etiology as much as possible. Nevertheless, when diagnosis is still unclear, or idiopathic and inflammatory markers are elevated, empiric anti-inflammatory therapy may be worthwhile. A true isolated effusion may not require a specific treatment if the patient is asymptomatic, but large ones have a theoretical risk of progression to cardiac tamponade (up to one-third) if subacute with signs of right-sided collapse, and especially chronic (>3 months). Pericardiocentesis alone may be curative for large effusions but recurrences are also common and pericardiectomy or less invasive options (i.e. pericardial window) should be considered whenever fluid re-accumulates (especially with tamponade), becomes loculated, or biopsy material is required.

Entities:  

Mesh:

Year:  2010        PMID: 20814314     DOI: 10.2459/JCM.0b013e32833e5788

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  17 in total

Review 1.  Immortalization protocols used in cell culture models of human breast morphogenesis.

Authors:  T Gudjonsson; R Villadsen; L Rønnov-Jessen; O W Petersen
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

2.  [Diagnostics and therapy of pericarditis and pericardial effusion].

Authors:  B Maisch; A D Ristić
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

3.  [Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis].

Authors:  B Maisch
Journal:  Herz       Date:  2018-11       Impact factor: 1.443

4.  Pericarditis: pathophysiology, diagnosis, and management.

Authors:  Massimo Imazio
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

5.  Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions.

Authors:  Sabine Pankuweit; Alexandra Stein; Konstantinos Karatolios; Anette Richter; Volker Ruppert; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

6.  [Progress or regress or both? ESC guidelines on pericardial diseases 2015].

Authors:  B Maisch
Journal:  Herz       Date:  2015-12       Impact factor: 1.443

7.  Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.

Authors:  Szymon Darocha; Michał Wilk; Anna Walaszkowska-Czyż; Jarosław Kępski; Rafał Mańczak; Marcin Kurzyna; Adam Torbicki; Sebastian Szmit
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

Review 8.  Evaluation of the Pericardium with CT and MR.

Authors:  Julianna M Czum; Anne M Silas; Morgan C Althoen
Journal:  ISRN Cardiol       Date:  2014-01-29

Review 9.  New Approaches to Management of Pericardial Effusions.

Authors:  George Lazaros; Charalambos Vlachopoulos; Emilia Lazarou; Konstantinos Tsioufis
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

Review 10.  Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis.

Authors:  Nicholas Schwier; Nicole Tran
Journal:  Pharmaceuticals (Basel)       Date:  2016-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.